BillionToOne, Inc. 是一家精准诊断公司,通过量化生物学来开发分子诊断产品。公司总部位于加利福尼亚州门洛帕克。
财务指标
营业收入
2026-06-30
$1.09亿
2026-03-31
$1.08亿
2025-12-31
$9605.3万
2025-09-30
$8352.3万
营业支出
2026-06-30
$7160.4万
2026-03-31
$6126.2万
2025-12-31
$5827.2万
2025-09-30
$4878.3万
净利润
2026-06-30
$805.4万
2026-03-31
$1797万
2025-12-31
$597.7万
2025-09-30
$150.7万
净利润率
2026-06-30
7.35%
2026-03-31
16.57%
2025-12-31
6.22%
2025-09-30
1.8%
每股收益
2026-06-30
$0.15
2026-03-31
$0.33
2025-12-31
$0.15
2025-09-30
$0.91
息税折旧摊销前利润
2026-06-30
$1092.2万
2026-03-31
$2150.9万
2025-12-31
$926万
2025-09-30
$855.4万
有效税率
2026-06-30
-7.12%
2026-03-31
2.91%
2025-12-31
5.08%
2025-09-30
-2.31%
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$1.09亿
$1.08亿
$9605.3万
$8352.3万
营业支出
$7160.4万
$6126.2万
$5827.2万
$4878.3万
净利润
$805.4万
$1797万
$597.7万
$150.7万
净利润率
7.35%
16.57%
6.22%
1.8%
每股收益
$0.15
$0.33
$0.15
$0.91
息税折旧摊销前利润
$1092.2万
$2150.9万
$926万
$855.4万
有效税率
-7.12%
2.91%
5.08%
-2.31%
常见问题
BLLN stock represents a publicly traded security listed on a U.S. exchange, giving investors exposure to the underlying company's business operations. Because no specific company details have been provided here, the most reliable way to understand what BLLN stock represents is to review the company profile, sector classification, and business description shown on this page.
BLLN's share price can be influenced by company-specific developments such as quarterly earnings, revenue trends, and management guidance, as well as broader market conditions like investor sentiment, sector rotation, and macroeconomic changes. Interest rate expectations, industry competition, and regulatory developments may also affect how the market values BLLN. Reviewing the latest BLLN news and financial disclosures can help investors understand which factors are currently most relevant.
Recent performance for BLLN depends on current market trading, so the most accurate figures are the latest price, daily change, and historical performance data displayed on this page. That data typically includes recent trading sessions, short-term trends, and longer-term comparisons. Investors often review these figures alongside volume and broader market benchmarks to assess how BLLN has been behaving relative to peers and the overall market.
Common valuation metrics for analyzing BLLN include the price-to-earnings (P/E) ratio, price-to-sales (P/S), price-to-book (P/B), and enterprise value multiples such as EV/EBITDA. Investors may also compare BLLN's metrics with those of industry peers and its own historical averages. These measures should be considered together, since a single metric rarely provides a complete picture of whether a stock is reasonably valued.
To buy BLLN stock, investors generally need a brokerage account that supports U.S. equity trading. Once the account is funded, BLLN can be purchased through the broker's platform using a market order or a limit order, depending on the preferred execution method. Availability of fractional shares and any applicable commissions or fees varies by broker, so reviewing the broker's terms before placing a trade is advisable.
Investing in BLLN carries risks such as market volatility, where the share price may decline due to broad market downturns or changing investor sentiment. Company-specific risks can include weaker-than-expected financial results, operational challenges, competitive pressure, or regulatory developments affecting its business. Investors should also consider liquidity risk and valuation risk, especially if BLLN's stock price has moved sharply. Reviewing BLLN's risk disclosures and financial statements can help clarify these factors.